November 29, 2016 / 9:20 PM / 9 months ago

BRIEF-Cerecor reports top-line data from CERC-301 Phase 2 study

Nov 29 (Reuters) - Cerecor Inc

* Cerecor reports top-line data from CERC-301 Phase 2 study for major depressive disorder

* Says CERC-301 misses primary endpoint

* Cerecor Inc says significant improvement was not observed on other secondary endpoints evaluated to date Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below